Can citalopram (Celex) and lisinopril be started together, and what are the appropriate dosing and monitoring recommendations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Citalopram and Lisinopril Be Started Together?

Yes, citalopram (Celexa) and lisinopril can be safely started together—there are no contraindications or clinically significant drug interactions between these medications. This combination is commonly used in clinical practice for patients requiring both antidepressant therapy and blood pressure management.

Safety Profile of the Combination

The combination of an SSRI (citalopram) with an ACE inhibitor (lisinopril) has been studied and used safely in clinical practice. Research specifically examining this combination in hypertensive patients with depression demonstrated that citalopram effectively corrected anxiodepressive disorders while lisinopril controlled blood pressure, with enhanced blood pressure reduction when used together 1.

There are no pharmacokinetic interactions between these drugs. Citalopram is primarily metabolized by CYP3A4 and CYP2C19 2, while lisinopril is not metabolized and is excreted unchanged by the kidneys 3. They do not interfere with each other's metabolism or elimination.

Dosing Recommendations

Lisinopril Dosing

  • Initial dose for hypertension: 10 mg once daily 3
  • Usual maintenance range: 20-40 mg once daily 3
  • Maximum dose: 40 mg daily (doses up to 80 mg have been used but show no greater effect) 3
  • Renal adjustment required: If creatinine clearance 10-30 mL/min, start with 5 mg daily; if <10 mL/min or on hemodialysis, start with 2.5 mg daily 3

Citalopram Dosing

  • Initial dose: Start with the lowest effective dose, typically 20 mg once daily 2
  • Maximum dose: 40 mg daily for adults ≤65 years; 20 mg daily maximum for adults >65 years 2
  • Timing: Can be taken at any convenient time of day to establish a habitual pattern and improve adherence 4, 2

Critical Monitoring Parameters

For Citalopram

QTc prolongation is the primary safety concern 2, 5. Before initiating:

  • Obtain baseline ECG if patient has cardiac disease, electrolyte abnormalities, or is taking other QTc-prolonging medications 2
  • Check electrolytes (potassium, magnesium) as hypokalemia increases QTc risk
  • Review all medications for QTc-prolonging drugs—avoid combinations when possible 2

Monitor for:

  • Suicidality, especially in first 4-8 weeks and after dose changes 2
  • Serotonin syndrome symptoms (agitation, confusion, tremor, hyperthermia) 2
  • Hyponatremia (more common in elderly) 6

For Lisinopril

Check within 1-2 weeks of initiation 3:

  • Renal function (serum creatinine, eGFR)
  • Serum potassium (risk of hyperkalemia)
  • Blood pressure response

Monitor for:

  • Hypotension, especially after first dose 3
  • Dry cough (occurs in up to 20% of patients) 7
  • Angioedema (rare but life-threatening; more common in Black patients) 7

Combined Monitoring

  • Blood pressure at each visit until controlled
  • Renal function and potassium every 3-6 months once stable
  • Depression symptoms using standardized scales (PHQ-9)
  • Adherence to both medications

Important Clinical Caveats

Age-Related Considerations

For patients >65 years:

  • Citalopram maximum dose is 20 mg daily (not 40 mg) due to increased QTc prolongation risk 2, 5
  • Consider starting lisinopril at 5 mg if frail or with low systolic BP 4
  • Monitor more closely for orthostatic hypotension with the combination

Contraindications to Watch

Do NOT use citalopram if:

  • Patient is taking MAOIs or within 14 days of MAOI discontinuation 2
  • History of QT prolongation or congenital long QT syndrome 2
  • Concurrent use of pimozide or other drugs that significantly prolong QTc 2

Do NOT use lisinopril if:

  • History of angioedema with any ACE inhibitor 3
  • Pregnancy or planning pregnancy 3
  • Bilateral renal artery stenosis 3

Drug Interaction Pitfalls

Avoid combining citalopram with:

  • Other serotonergic drugs (triptans, tramadol, St. John's Wort, other SSRIs/SNRIs) due to serotonin syndrome risk 2
  • Multiple QTc-prolonging medications (antipsychotics, certain antibiotics, antiarrhythmics) 2, 5

Caution with lisinopril and:

  • NSAIDs (reduce antihypertensive effect, increase renal dysfunction risk) 8
  • Potassium supplements or potassium-sparing diuretics (hyperkalemia risk) 3
  • Other antihypertensives (additive hypotensive effects)

Practical Implementation Strategy

Week 0 (Initiation):

  1. Obtain baseline labs: electrolytes, renal function, ECG if indicated
  2. Start lisinopril 10 mg once daily (5 mg if >85 years or frail)
  3. Start citalopram 20 mg once daily (10 mg if >65 years or concerns about tolerability)
  4. Counsel on hypotension symptoms and when to seek care

Week 1-2:

  • Recheck blood pressure, renal function, potassium
  • Assess for hypotension, cough, mood changes, suicidality
  • Adjust lisinopril dose based on BP response

Week 4-6:

  • Reassess depression symptoms
  • Consider citalopram dose increase if inadequate response (max 40 mg if ≤65 years, max 20 mg if >65 years)
  • Titrate lisinopril to target BP (typically 20-40 mg daily)

Month 3:

  • Target BP should be achieved: <130/80 mmHg for most patients 4, 9
  • Depression should show significant improvement
  • Establish long-term monitoring schedule

Treatment Duration

For depression: First episode requires minimum 4-6 months of treatment after remission; recurrent depression may require indefinite treatment 6

For hypertension: Lifelong treatment is recommended, even beyond age 85 if well tolerated 4

This combination represents evidence-based therapy for comorbid depression and hypertension, with complementary mechanisms and no significant drug interactions when properly monitored.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.